Journal article
Authors list: Alidjanov, Jakhongir F.; Cai, Tommaso; Bartoletti, Riccardo; Bonkat, Gernot; Bruyere, Franck; Koves, Bela; Kulchavenya, Ekaterina; Medina-Polo, Jose; Naber, Kurt; Perepanova, Tamara; Pilatz, Adrian; Tandogdu, Zafer; Bjerklund Johansen, Truls E.; Wagenlehner, Florian M.
Publication year: 2021
Pages: 3423-3432
Journal: World Journal of Urology
Volume number: 39
Issue number: 9
ISSN: 0724-4983
eISSN: 1433-8726
Open access status: Hybrid
DOI Link: https://doi.org/10.1007/s00345-021-03614-8
Publisher: Springer
Abstract:
Purpose To evaluate and report the complications, and to analyse antimicrobial stewardship aspects following prostate biopsies (P-Bx) based on the data from a 9-year global study. Methods The primary outcome was to compare complications after P-Bx between patients of two cohorts: 2010-2014 and 2016-2019. Primary outcomes included symptoms of lower and severe/systemic urinary tract infection (LUTIS and SUTIS, respectively), and positive urine culture. Readmission to hospital after P-Bx, need for additional antimicrobial therapy, consumption of different antimicrobial agents for prophylaxis and therapy were evaluated. Students t test and chi-square test were used for comparative analyses. Results Outcome data were available for 1615 men. Fluoroquinolones-based prophylaxis rate increased from 72.0% in 2010-2014 to 78.6% in 2015-2019. Overall rates of complications increased from 6 to 11.7% including an increase in symptomatic complications from 4.7 to 10.2%, mainly due to an increase in LUTIS. Rates of patients seeking additional medical help in primary care after P-Bx increased from 7.4 to 14.4%; cases requiring post P-Bx antibiotic treatment increased from 6.1 to 9.7%, most of which received fluoroquinolones. Transperineal P-Bx was significantly associated with LUTIS. Following transrectal P-Bx, 2.8% developed febrile infections and 4.0% required hospitalisation. Two men (0.12%) died after transrectal P-Bx due to sepsis. Conclusions The rates of complications after P-Bx tended to increase in time, as well as rates of patients seeking additional medical help in the post-P-Bx period. To reduce the risk of infectious complications and to comply with the principles of antibiotic stewardship, clinicians should switch to the transperineal biopsy route.
Citation Styles
Harvard Citation style: Alidjanov, J., Cai, T., Bartoletti, R., Bonkat, G., Bruyere, F., Koves, B., et al. (2021) The negative aftermath of prostate biopsy: prophylaxis, complications and antimicrobial stewardship: results of the global prevalence study of infections in urology 2010-2019, World Journal of Urology, 39(9), pp. 3423-3432. https://doi.org/10.1007/s00345-021-03614-8
APA Citation style: Alidjanov, J., Cai, T., Bartoletti, R., Bonkat, G., Bruyere, F., Koves, B., Kulchavenya, E., Medina-Polo, J., Naber, K., Perepanova, T., Pilatz, A., Tandogdu, Z., Bjerklund Johansen, T., & Wagenlehner, F. (2021). The negative aftermath of prostate biopsy: prophylaxis, complications and antimicrobial stewardship: results of the global prevalence study of infections in urology 2010-2019. World Journal of Urology. 39(9), 3423-3432. https://doi.org/10.1007/s00345-021-03614-8
Keywords
GPIU; Prostate biopsy; URINARY-TRACT-INFECTIONS; WORLDWIDE SURVEILLANCE